Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
03 May 2019 | Story Ruan Bruwer
Lynique Beneke
Lynique Beneke, long jump athlete of the University of the Free State and the national women’s champion seven times in a row, hopes to qualify for the World Championships.

The long jumper, Lynique Beneke, dreams of going to another Olympic Games and jumping over seven metres before she retires.

In between, there is still a World Championship later in the year for which she is trying to qualify. The qualifying standard is 6,72 m, not far from the 6,64 m she achieved at the national athletics championships at the end of April, which earned her a seventh consecutive national crown. At the time, it was the seventh best globally. She will have to qualify in Europe, as the South African season is over.

“With my faith as my biggest support, my mom and I both dreamed about me jumping exactly the same distance of 7,03 m! That is my big goal. I know I can do that,” Beneke (28) said. Her personal best is 6,81 m.

Special bond with coach


She is currently studying Education (BEd Senior and FET phase). “At this moment, I’m focusing on finishing my degree and enjoying my athletics. I want to give my athletics a fair chance, as I am only getting into prime shape now at this age. Once I’m done with athletics, I will focus on a career.”

According to Beneke, a 2016 Olympian and the Kovsie Senior Sportswoman of the Year for 2018, consistency is the name of her game. “I show up, even when I don’t feel like it. I push myself every day. I feel I have so much left in the tank, and that motivates me. All the glory to God.”

She is married to the hurdler, PC (also a Kovsie student). They moved from Gauteng to Bloemfontein at the end of 2017.

“My coach, Emmarie Fouché, was the big influence (coming here). I started working with her at the end of 2015. We work perfectly together; we are both women and have the same work ethic. She understands me. We are very close, and I think that is what makes the difference.”


News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept